Albert David Limited (BOM:524075)

India flag India · Delayed Price · Currency is INR
715.35
+4.80 (0.68%)
At close: Apr 28, 2026
-14.88%
Market Cap 4.08B
Revenue (ttm) 3.23B
Net Income (ttm) 96.12M
Shares Out 5.71M
EPS (ttm) 16.84
PE Ratio 42.48
Forward PE n/a
Dividend 5.00 (0.70%)
Ex-Dividend Date Jul 25, 2025
Volume 151
Average Volume 437
Open 727.25
Previous Close 710.55
Day's Range 714.50 - 733.00
52-Week Range 581.30 - 959.35
Beta 0.12
RSI 55.32
Earnings Date May 13, 2026

About Albert David

Albert David Limited manufactures and trades in pharmaceutical formulations, infusion solutions, herbal dosage forms, and bulk drugs in India and internationally. It offers formulations for parenterals, oral/enterals, topical agents, aerosol, gynecology therapy, orthopedic, and vision care products. Albert David Limited was incorporated in 1938 and is headquartered in Kolkata, India. [Read more]

Industry Pharmaceutical Preparations
Founded 1938
Employees 1,805
Stock Exchange Bombay Stock Exchange
Ticker Symbol 524075
Full Company Profile

Financial Performance

In fiscal year 2025, Albert David's revenue was 3.46 billion, a decrease of -4.61% compared to the previous year's 3.62 billion. Earnings were 172.01 million, a decrease of -77.19%.

Financial Statements

News

There is no news available yet.